Oxford Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-23,285
| Closed | -$1.7M | – | 1735 |
|
|
2019
Q3 | $1.7M | Sell |
23,285
-31,507
| -58% | -$2.3M | 0.04% | 637 |
|
|
2019
Q2 | $4.5M | Buy |
54,792
+44,571
| +436% | +$3.66M | 0.1% | 271 |
|
|
2019
Q1 | $721K | Buy |
10,221
+703
| +7% | +$49.6K | 0.02% | 1073 |
|
|
2018
Q4 | $429K | Buy |
9,518
+3,068
| +48% | +$138K | 0.01% | 1252 |
|
|
2018
Q3 | $361K | Sell |
6,450
-31,783
| -83% | -$1.78M | 0.01% | 1435 |
|
|
2018
Q2 | $2.57M | Sell |
38,233
-13,803
| -27% | -$927K | 0.05% | 509 |
|
|
2018
Q1 | $3.03M | Buy |
52,036
+3,708
| +8% | +$216K | 0.06% | 357 |
|
|
2017
Q4 | $3.18M | Buy |
+48,328
| New | +$3.18M | 0.07% | 355 |
|
|
2016
Q4 | – | Sell |
-21,986
| Closed | -$1.46M | – | 760 |
|
|
2016
Q3 | $1.46M | Sell |
21,986
-57,903
| -72% | -$3.84M | 0.05% | 453 |
|
|
2016
Q2 | $4.46M | Buy |
79,889
+13,810
| +21% | +$771K | 0.15% | 168 |
|
|
2016
Q1 | $2.22M | Sell |
66,079
-93,228
| -59% | -$3.14M | 0.06% | 352 |
|
|
2015
Q4 | $7.18M | Buy |
+159,307
| New | +$7.18M | 0.17% | 123 |
|